Cartesian Therapeutics, Inc. — Director's Dealing 2016

Jun 29, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-06-27

Reporting Person: VTB Capital I2BF Netherlands, B.V. (10% Owner)
Reporting Person: Selecta RKFN, Ltd. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-27	Common Stock	C	178890	—	Acquired	178890	Indirect
2016-06-27	Common Stock	C	178890	—	Acquired	178890	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-27	Series SRN Convertible Preferred Stock	$	C	178890	Disposed		Common Stock (178890)	Indirect
2016-06-27	Series SRN Convertible Preferred Stock	$	C	178890	Disposed		Common Stock (178890)	Indirect

Footnotes

F1: The preferred stock is convertible at any time, at the holder's election and has no expiration date. The preferred stock automatically converted into common stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering.